Signant Health expands availability of its eClinical solutions by joining the IQVIA One Home for Sites initiative

PHILADELPHIA, September 4, 2024 /PRNewswire/ — Signant Health, the leader in evidence generation for modern clinical trials, today announced that it has joined IQVIA, a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, in the One Home for Sites initiative.

IQVIA One Home for Sites is an industry-wide collaboration designed to simplify site behavior when clinical research staff are using multiple eClinical technologies from multiple solution providers for a trial. Through single sign-on to a common platform, sites will enjoy simplified access to trial technologies from IQVIA and other technology partners who have taken the steps to participate in One Home.